SHANNON BORDES: Open Payments
NPI 1851831200 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 44 payments from 10 companies in 2025. Trend: 2023 $1,406 · 2024 $2,146 · 2025 $887
Food & beverage: $887
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $281 |
| Madrigal Pharmaceuticals | 5 | $185 |
| Ipsen Biopharmaceuticals, Inc | 2 | $142 |
| Regeneron Healthcare Solutions, Inc. | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| GENZYME CORPORATION | 3 | $57 |
| PFIZER INC. | 2 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Celltrion USA Inc. | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $15 |
Products named: REZDIFFRA, RINVOQ, IQIRVO, DUPIXENT, SKYRIZI, ENTYVIO, MAVYRET, TERLIVAZ.
Industry payments across ID — which companies pay providers there.
